Alteration of purinergic signaling in diabetes: Focus on vascular function (Q89712805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

review article

1 reference

title

Alteration of purinergic signaling in diabetes: Focus on vascular function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Rui Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Xitong Dang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Randy S Sprague

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

S Jamal Mustafa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Zhichao Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

publication date

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

8 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

1-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

8 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Macro- and microvascular endothelial dysfunction in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Purinergic Signaling in the Cardiovascular System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Purinergic transmission in blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Control of vascular tone by purines and pyrimidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Purine and pyrimidine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Cardiovascular adenosine receptors: expression, actions and interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Introduction: P2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

P2 receptors in cardiovascular regulation and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Purinergic Signalling and Endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Role of insulin and adenosine in the human placenta microvascular and macrovascular endothelial cell dysfunction in gestational diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Altered Purinergic Receptor Sensitivity in Type 2 Diabetes-Associated Endothelial Dysfunction and Up₄A-Mediated Vascular Contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Relaxation of rat aorta by adenosine in diabetes with and without hypertension: role of endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long-Evans Tokushima Fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Mechanisms underlying reduced P2Y(1) -receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Attenuated purinergic receptor function in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

P2 receptors in renal autoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Vasoconstrictor and vasodilator effects of adenosine in the kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Purinergic signaling in kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Renal vasculature reactivity to agonist of P2X7 receptor is increased in streptozotocin-induced diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

A2B adenosine receptor-mediated induction of IL-6 promotes CKD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Exogenously administered adenosine attenuates renal damage in streptozotocin-induced diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine A2 a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Targeting adenosine signaling to treatment of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine A(2B) receptor-mediated VEGF induction promotes diabetic glomerulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or to N-acetylcysteine supplementation [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Purinergic signaling in the retina: From development to disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Role of P2X7 receptors in the development of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Phosphoinositide metabolism and prostacyclin formation in retinal microvascular endothelium: stimulation by adenine nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Diabetic Retinopathy: Pathophysiology and Treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

P2X7 receptor antagonism: Implications in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

NAD+-induced vasotoxicity in the pericyte-containing microvasculature of the rat retina: effect of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Effect of P2X7 receptor activation on the retinal blood velocity of diabetic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

The P2X7 Receptor in Infection and Inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Interactions between A(2A) adenosine receptors, hydrogen peroxide, and KATP channels in coronary reactive hyperemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

A G-coupled purinergic receptor boosts Ca influx and vascular contractility during diabetic hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Diabetes and impaired response of glucagon cells and vascular bed to adenosine in rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Type 2 diabetes specifically attenuates purinergic skin vasodilatation without affecting muscarinic and nicotinic skin vasodilatation and sweating.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

ATP and norepinephrine contributions to sympathetic vasoconstriction of tail artery are altered in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Erythrocytes and Vascular Function: Oxygen and Nitric Oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Red blood cell dysfunction: a new player in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Erythrocytes and cardiovascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Endothelial nitric oxide synthase in red blood cells: key to a new erythrocrine function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

The Effect of Glycemic Control on Endothelial and Cardiac Dysfunction Induced by Red Blood Cells in Type 2 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

ATP as a mediator of erythrocyte-dependent regulation of skeletal muscle blood flow and oxygen delivery in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Mechanisms of ATP release and signalling in the blood vessel wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Regulation of cAMP by phosphodiesterases in erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Divergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Diabetes and Vascular Disease: Is It All About Glycemia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Diabetes and antiplatelet therapy: from bench to bedside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

High glucose activates nuclear factor of activated T cells in native vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2020.02.004

Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats

7 January 2021

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

Involvement of purinergic signaling in cardiovascular diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

Role of insulin, adenosine, and adipokine receptors in the foetoplacental vascular dysfunction in gestational diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/32057736

12 December 2020

10.1016/J.YJMCC.2020.02.004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32057736%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

PMC publication ID

7425578

0 references

1 reference